GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ginkgo Bioworks Holdings Inc (NYSE:DNA.WS) » Definitions » Long-Term Capital Lease Obligation

Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) Long-Term Capital Lease Obligation : $234.50 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ginkgo Bioworks Holdings Long-Term Capital Lease Obligation?

Ginkgo Bioworks Holdings's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $234.50 Mil.

Ginkgo Bioworks Holdings's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 ($403.66 Mil) to Dec. 2023 ($221.84 Mil) but then increased from Dec. 2023 ($221.84 Mil) to Mar. 2024 ($234.50 Mil).

Ginkgo Bioworks Holdings's annual Long-Term Capital Lease Obligation increased from Dec. 2021 ($22.28 Mil) to Dec. 2022 ($413.26 Mil) but then declined from Dec. 2022 ($413.26 Mil) to Dec. 2023 ($221.84 Mil).


Ginkgo Bioworks Holdings Long-Term Capital Lease Obligation Historical Data

The historical data trend for Ginkgo Bioworks Holdings's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ginkgo Bioworks Holdings Long-Term Capital Lease Obligation Chart

Ginkgo Bioworks Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
- 16.52 22.28 413.26 221.84

Ginkgo Bioworks Holdings Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 404.10 410.94 403.66 221.84 234.50

Ginkgo Bioworks Holdings  (NYSE:DNA.WS) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Ginkgo Bioworks Holdings Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Ginkgo Bioworks Holdings's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) Business Description

Traded in Other Exchanges
Address
27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Foundry and Biosecurity. The Biosecurity segment generates the majority of revenue.